Skip to main content
. 2016 Dec 20;158(4):660–668. doi: 10.1097/j.pain.0000000000000810

Figure 2.

Figure 2.

Plasma and brain exposure of anti-transferrin variants in a mouse PK assay. (A) Plasma PK of anti-TfR variants and isotype control (NIP228) over a 2-week period. N = 6 per group (B) Brain exposure as a measure of % injected dose per gram of brain. (C) Spinal cord exposure as a measure of % injected dose per gram of spinal cord. PK, pharmokinetic; TfR, transferrin receptor.